{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:43:27Z","timestamp":1780962207313,"version":"3.54.1"},"reference-count":34,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent evidence suggests that the practice of combining opioid use with non-opioid substances is common, though little is known about this phenomenon and how best to address it.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We recruited adults in Boston, Massachusetts, with recent opioid use. We conducted semi-structured interviews to explore the practice of combining non-opioid substances with opioids and analyzed transcripts to identify themes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-nine individuals completed interviews. Combining other substances with opioids was a well-known practice: \u201cthat's what we call the cocktail.\u201d Participants reported the use of clonidine, gabapentin, benzodiazepines, promethazine, amphetamine salts, quetiapine, barbiturates, cough and cold medications, as well as alcohol and candy in combination with opioids. Participants reported purchasing these substances on the street, stealing them, or getting them from a prescriber. Augmenting the opioid high was a common reason for combining substances. Importantly, participants also reported combining substances to treat psychiatric symptoms. Individuals commonly reported learning about combining substances \u201cfrom people on the street\u201d but also reported learning from the internet and television. Perceived benefits outweighed safety concerns. Participants also felt that using over-the-counter or prescription medications would be safe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combining a variety of substances with opioids is common and driven by diverse motives. Clinicians caring for opioid-involved patients should consider screening for concurrent use of other substances and discussing the risks of this practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1080\/08897077.2019.1671943","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T12:25:55Z","timestamp":1571833555000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":16,"title":["\u201cThat'S What We Call the Cocktail\u201d: Non-Opioid Medication and Supplement Misuse among Opioid Users"],"prefix":"10.1177","volume":"42","author":[{"given":"Avik","family":"Chatterjee","sequence":"first","affiliation":[{"name":"Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, Massachusetts, USA"},{"name":"Division of Global Health Equity, Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Lopez","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Ramkellawan","sequence":"additional","affiliation":[{"name":"Harvard College, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Brown","sequence":"additional","affiliation":[{"name":"Harvard College, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Smith","sequence":"additional","affiliation":[{"name":"Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie M.","family":"Gaeta","sequence":"additional","affiliation":[{"name":"Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, Massachusetts, USA"},{"name":"Division of General Internal Medicine, Department of General Internal Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis P.","family":"Baggett","sequence":"additional","affiliation":[{"name":"Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, Massachusetts, USA"},{"name":"Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"Overdose Death Rates. National Institute on Drug Abuse Website. https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates. Published September 2017. Accessed February 3 2018."},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.1604"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031914-122957"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6626a4"},{"key":"e_1_3_4_6_1","unstructured":"Ahmad FB Escobedo LA Rossen LM SpencerMR Warner MS. Provisional drug overdose death counts. Centers for Disease ontrol and Preventionfor Disease Control Vital Statistics Rapid Release. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm. Published 2019. Accessed July 26 2019."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.01.018"},{"key":"e_1_3_4_8_1","unstructured":"The Massachusetts Opioid Epidemic: A data visualization of findings from the Chapter 55 report. Massachusetts Department of Public Health Website. https:\/\/chapter55.digital.mass.gov\/. Published 2017. Accessed April 7 2019."},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010375727768"},{"key":"e_1_3_4_10_1","unstructured":"Carmen Heredia Rodriguez. New on the streets: Gabapentin a drug for nerve pain becomes a new target of abuse. STAT. July 6 2017. https:\/\/www.statnews.com\/2017\/07\/06\/gabapentin-becomes-target-of-opioid-abuse\/"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12159"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-209705"},{"key":"e_1_3_4_13_1","unstructured":"Opiate Potentiation Guide \u2013 The ultimate list. Khemcorp \u2013 solutions for autism social anxiety ADHD and drug tolerance. https:\/\/www.khemcorp.com\/opiate-potentiation-guide-the-ultimate-list\/. Published September 2015. Accessed February 3 2018."},{"key":"e_1_3_4_14_1","unstructured":"Combinations \u2013 Opiate\/opiod potentiating guide. Drugs-forum. https:\/\/drugs-forum.com\/threads\/opiate-opiod-potentiating-guide.129909\/. Accessed February 3 2018."},{"key":"e_1_3_4_15_1","unstructured":"Possible grapefruit juice potential for greater tramadol experience. Drugs-forums. https:\/\/wayback.archive-it.org\/693\/20161023162637\/https:\/\/drugs-forum.com\/forum\/showthread.php?p=1397892. Published 2016. Accessed June 8 2019."},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2010.00582.x"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.03.007"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02209.x"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2710.2002.00444.x"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6814a2"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0595-1"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002396"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13339"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2018.1535150"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntx178"},{"key":"e_1_3_4_26_1","first-page":"179","volume-title":"Doing Qualitative Research","author":"Borkan J.","year":"1999","unstructured":"Borkan J. Immersion\/crystallization. In: Crabtree B, , Miller W, eds. Doing Qualitative Research. 2nd ed. Thousand Oaks, CA: SAGE Publications; 1999:179\u2013194.","edition":"2"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6614a2"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)60750-7"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.033878"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199610000-00009"},{"issue":"3","key":"e_1_3_4_31_1","first-page":"235","article-title":"Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies","volume":"88","author":"Hawk KF","year":"2015","unstructured":"Hawk KF, , Vaca FE, , D'Onofrio G. Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies. Yale J Biol Med. 2015;88(3):235\u2013245.","journal-title":"Yale J Biol Med."},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.04.012"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-015-3199-4"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.07.012"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S168504"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1671943","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2019.1671943","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1671943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:27:36Z","timestamp":1780507656000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2019.1671943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1080\/08897077.2019.1671943"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2019.1671943","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}